Gastrointestinal stromal tumour, primary site (Q38808): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Este é o tumor mesenquimal mais comum que se origina no trato gastrointestinal. Geralmente é imunohistoquimicamente positivo para CD117 (KIT), fenotipicamente em paralelo com a diferenciação de células de Cajal, na maioria dos casos apresentam mutações ativadoras de KIT ou PDGFRA. É mais frequente no estômago e em menor grau no intestino delgado. O prognóstico depende do tamanho do tumor e da atividade mitótica. | |||
| description / en | description / en | ||
This is the most common mesenchymal tumour that arises in the gastrointestinal tract. It is generally immunohistochemically positive for CD117 (KIT), phenotypically paralleling Cajal-cell differentiation, and most examples contain KIT- or PDGFRA-activating mutations. It is most frequent in the stomach and to a lesser degree in the small intestine. The prognosis depends on the tumour size and the mitotic activity. | |||
Revision as of 04:02, 13 August 2026
This is the most common mesenchymal tumour that arises in the gastrointestinal tract. It is generally immunohistochemically positive for CD117 (KIT), phenotypically paralleling Cajal-cell differentiation, and most examples contain KIT- or PDGFRA-activating mutations. It is most frequent in the stomach and to a lesser degree in the small intestine. The prognosis depends on the tumour size and the mitotic activity.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2B5B |
||
| English | Gastrointestinal stromal tumour, primary site |
This is the most common mesenchymal tumour that arises in the gastrointestinal tract. It is generally immunohistochemically positive for CD117 (KIT), phenotypically paralleling Cajal-cell differentiation, and most examples contain KIT- or PDGFRA-activating mutations. It is most frequent in the stomach and to a lesser degree in the small intestine. The prognosis depends on the tumour size and the mitotic activity. |
